Efficacy and safety of lamivudine (3TC) in renal transplant patients with chronic hepatitis B.

被引：0
|
作者：
Antoine, C
Landau, A
Menoyo, V
Duong, JP
Duboust, A
Glotz, D
机构：
[1] Hop Broussais, Sce Nephrol, F-75674 Paris, France
[2] Hop Broussais, Sce Gastroenterol, F-75674 Paris, France
[3] Hop Broussais, Sce Anatomopathol, F-75674 Paris, France
[4] Inserm U430, Paris, France
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00865
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
841
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 50 条
  • [31] P gene variants and response to lamivudine in patients with chronic hepatitis B.
    Buti, M
    Rodriguez-Frias, F
    Eva, CD
    Cotrina, M
    Esteban, R
    Guardia, J
    HEPATOLOGY, 1999, 30 (04) : 646A - 646A
  • [32] THE EFFICACY OF LAMIVUDINE TREATMENT IN NAIVE CHRONIC HEPATITIS B PATIENTS
    Balkan, Ayhan
    Barutcu, Sezgin
    Erdem, Ramazan
    Konduk, Bugra Tolga
    Yildirim, Abdullah Emre
    Gulsen, Murat Taner
    ACTA MEDICA MEDITERRANEA, 2016, 32 (03): : 663 - 667
  • [33] Lamivudine treatment for liver transplant patients with recurrent or de novo hepatitis B.
    Andreone, P
    Caraceni, P
    Grazi, GL
    Ercolani, G
    Milandri, GL
    Morelli, C
    Biselli, M
    Polifemo, AM
    DalMonte, PR
    Roda, E
    Mazziotti, A
    Cavallari, A
    Bernardi, M
    HEPATOLOGY, 1997, 26 (04) : 1380 - 1380
  • [34] Efficacy of lamivudine for prophylaxis and treatment of hepatitis B in liver transplant patients
    Markowitz, J
    Pakrasi, A
    Hollis, P
    Martin, P
    Goldstein, L
    Busuttil, R
    HEPATOLOGY, 1996, 24 (04) : 222 - 222
  • [35] Comparison of treatment efficacy with lamivudine (3TC) and interferon-alfa (IFN) in chronic HBV infection
    Wawrzynowicz-Syczewska, M
    Urbanowicz, W
    Jurczyk, K
    Karpinska, E
    Boron, A
    JOURNAL OF HEPATOLOGY, 2000, 32 : 185 - 185
  • [36] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Senturk, H.
    Schiff, E.
    Brett-Smith, H.
    Zink, R.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S87 - S87
  • [37] Efficacy and safety of Adefovir for the treatment of patients with chronic hepatitis B (CHB) resistant to lamivudine in Spain
    Buti, M
    Esteban, R
    Escartin, P
    Calleja, JL
    Enriquez, J
    Pons, F
    Crespo, J
    Bengoechea, MG
    Prieto, M
    Casanovas, T
    Samaniego, JG
    Miras, M
    Roldan, FP
    Pelaez, M
    Fraga, E
    Moreira, V
    Carro, PG
    Rueda, M
    JOURNAL OF HEPATOLOGY, 2004, 40 : 125 - 125
  • [38] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Chang, Ting-Tsung
    Chao, You-Chen
    Wu, Shun-Sheng
    Tan, Chee Kia
    Rosmawati, Mohamed
    Lee, Alice
    George, Jacob
    Brett-Smith, Helena
    Zink, Richard
    Neo, Boon-Leong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A127 - A127
  • [39] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Chang, Ting-Tsung
    Chao, You-Chen
    Wu, Shun-Sheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A14 - A14
  • [40] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Schiff, E
    Lee, WM
    Chao, YC
    Sette, H
    Schalm, SW
    Brett-Smith, H
    Zink, R
    HEPATOLOGY, 2005, 42 (04) : 583A - 584A
12345